Deep dorsal vein embolization with N-butyl-2-cyanoacrylate and lipiodol mixture in venogenic erectile dysfunction: early and late results

Basit Öğe Kaydı
dc.authoridKutlu, Ramazan/0000-0001-7941-7025
dc.authorwosidSoylu, Ahmet/P-2015-2019
dc.authorwosidKutlu, Ramazan/AAE-5219-2020
dc.contributor.authorKutlu, Ramazan
dc.contributor.authorSoylu, Ahmet
dc.date.accessioned2024-08-04T20:31:09Z
dc.date.available2024-08-04T20:31:09Z
dc.date.issued2009
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground. The aim of the study was to perform and evaluate pelvic venoablation with N-butyl-2-cyanoacrilate (NBCA) and lipiodol injection into the deep dorsal vein for the treatment of 32 patients with venogenic erectile dysfunction. Methods. A total of 32 patients with the confirmed diagnosis of venogenic erectile dysfunction, with (n = 15) or without (n = 17) associated comorbidities were included. Deep dorsal veins were embolized with NBCA and lipiodol mixture. All patients were evaluated using the erectile function domain of the International Index of Erectile Function questionnaire (IIEF) before, at 3 months and 1 year after embolization. Results. While the post-operative 3(rd) month scores were increased significantly in all groups (p < 0.001), there was a significant decrease at 12(th) month when compared to that of 3rd month (p < 0.001). But this decrease was significantly higher than those of preoperative values (p < 0.001). In patients without comorbidities post-operative 3rd and 12(th) month scores were significantly higher than that of patients with comorbidities (p < 0.04 and p < 0.02, respectively). Although scores at 12(th) month were significantly higher compared to preoperative values, patients with comorbidities were dissatisfied with the quality of erection. Conclusions. Our pelvic venoablation technique was effective short-term. A limitation of this technique is that some patients are not candidates for this procedure due to comorbidites.en_US
dc.identifier.doi10.2478/v10019-009-0011-2
dc.identifier.endpage25en_US
dc.identifier.issn1318-2099
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-62949175336en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage17en_US
dc.identifier.urihttps://doi.org/10.2478/v10019-009-0011-2
dc.identifier.urihttps://hdl.handle.net/11616/94769
dc.identifier.volume43en_US
dc.identifier.wosWOS:000264922200003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherAssoc Radiology & Oncologyen_US
dc.relation.ispartofRadiology and Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectn-Butyl-2-cyanoacrylateen_US
dc.subjectlipiodolen_US
dc.subjectvenous impotenceen_US
dc.subjectdeep dorsal veinen_US
dc.subjectembolizationen_US
dc.titleDeep dorsal vein embolization with N-butyl-2-cyanoacrylate and lipiodol mixture in venogenic erectile dysfunction: early and late resultsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu